Profile
Yves Julien served as an Independent Director at Atrium Innovations, Inc. from 2011 to 2013.
Prior to that, he worked as a Managing Director at Merrill Lynch International, Inc. (China).
He also served as a Member at Global Diversified Investment Grade Income Trust.
Dr. Julien holds a doctorate degree from Rensselaer Polytechnic Institute.
Former positions of Yves Julien
| Companies | Position | End |
|---|---|---|
| ATRIUM INNOVATIONS INC. | Director/Board Member | 2013-05-13 |
| GLOBAL DIVERSIFIED INVESTMENT GRADE INCM | Corporate Officer/Principal | - |
| Merrill Lynch International, Inc. (China) | Corporate Officer/Principal | - |
Training of Yves Julien
| Rensselaer Polytechnic Institute | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Global Diversified Investment Grade Income Trust
 Global Diversified Investment Grade Income Trust Investment Trusts/Mutual FundsMiscellaneous Global Diversified Investment Grade Income Trust is a close-end investment fund and investment trust. The company is headquartered in Montreal, Canada. | Miscellaneous |
Atrium Innovations, Inc.
 Atrium Innovations, Inc. Pharmaceuticals: OtherHealth Technology Atrium Innovations, Inc. develops, manufactures and commercializes science-based nutritional health products. Its brands include Garden of Life, Seroyal, Trophic, Orthica, Genestra Brands, Minami, Wild Rose, and Pharmax. The company was founded by Eric Dupont and Luc Dupont in 1999 and is headquartered in Westmount, Canada. | Health Technology |
| Merrill Lynch International, Inc. (China) | Finance |
- Stock Market
- Insiders
- Yves Julien
